Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaia Skibinski

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
FEBS Letters|March 6, 2013
Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative diseaseGaia Skibinski, Steven Finkbeiner
International Journal of High Throughput Screening|March 19, 2013
Drug discovery in Parkinson's disease-Update and developments in the use of cellular modelsGaia Skibinski, Steven Finkbeiner
Stem Cell Research|November 4, 2021
Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson's patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
Stem Cell Research|November 26, 2021
Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson's disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
Cell and Tissue Research|December 14, 2017
iPS cells in the study of PD molecular pathogenesisMelanie M Cobb, Abinaya Ravisankar, Gaia Skibinski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 10, 2014
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesGaia Skibinski, Ken Nakamura, Mark R Cookson, et al.
Stem Cell Research|April 4, 2022
Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson's disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
Biometrics|January 30, 2016
A three-groups model for high-throughput survival screensBenjamin A Shaby, Gaia Skibinski, Michael Ando, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 15, 2010
Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosisSami J Barmada, Gaia Skibinski, Erica Korb, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2016
Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasisGaia Skibinski, Vicky Hwang, Dale Michael Ando, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
FEBS Letters|March 6, 2013
Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative diseaseGaia Skibinski, Steven Finkbeiner
International Journal of High Throughput Screening|March 19, 2013
Drug discovery in Parkinson's disease-Update and developments in the use of cellular modelsGaia Skibinski, Steven Finkbeiner
Stem Cell Research|November 4, 2021
Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson's patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
Stem Cell Research|November 26, 2021
Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson's disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
Cell and Tissue Research|December 14, 2017
iPS cells in the study of PD molecular pathogenesisMelanie M Cobb, Abinaya Ravisankar, Gaia Skibinski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 10, 2014
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesGaia Skibinski, Ken Nakamura, Mark R Cookson, et al.
Stem Cell Research|April 4, 2022
Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson's disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
Biometrics|January 30, 2016
A three-groups model for high-throughput survival screensBenjamin A Shaby, Gaia Skibinski, Michael Ando, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 15, 2010
Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosisSami J Barmada, Gaia Skibinski, Erica Korb, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2016
Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasisGaia Skibinski, Vicky Hwang, Dale Michael Ando, et al.
Pageof 2